DBV Technologies S.A. Announces Board and Compensation Changes
Ticker: DBVTF · Form: 8-K · Filed: Dec 18, 2024 · CIK: 1613780
| Field | Detail |
|---|---|
| Company | Dbv Technologies S.A. (DBVTF) |
| Form Type | 8-K |
| Filed Date | Dec 18, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, compensation
TL;DR
DBV Tech shakes up board & exec pay. Big changes coming?
AI Summary
DBV Technologies S.A. announced on December 16, 2024, changes in its board of directors and executive compensation arrangements. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for key personnel. Specific details regarding the individuals involved and the financial implications of these changes are outlined within the report.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, and future financial performance.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation can indicate internal shifts that may impact future performance and strategy.
Key Players & Entities
- DBV Technologies S.A. (company) — Registrant
- December 16, 2024 (date) — Date of earliest event reported
FAQ
Who are the specific directors or officers who have departed from DBV Technologies S.A.?
The filing indicates the departure of certain officers and directors, but specific names are not listed in the provided text.
When were the new directors elected to the board of DBV Technologies S.A.?
The filing states that new directors were elected as part of the events reported on December 16, 2024.
What specific changes were made to the compensatory arrangements of certain officers?
The filing mentions updates to compensatory arrangements for certain officers, but the exact details of these changes are not provided in the excerpt.
What is the primary business of DBV Technologies S.A.?
DBV Technologies S.A. is in the business of Biological Products (No Diagnostic Substances), as indicated by its Standard Industrial Classification code [2836].
Where is DBV Technologies S.A. headquartered?
DBV Technologies S.A. is headquartered in Châtillon, France, with its principal executive offices located at 107 avenue de la République.
Filing Stats: 1,303 words · 5 min read · ~4 pages · Grade level 13.9 · Accepted 2024-12-18 16:06:01
Filing Documents
- d895886d8k.htm (8-K) — 37KB
- d895886dex101.htm (EX-10.1) — 20KB
- d895886dex102.htm (EX-10.2) — 4KB
- g895886g1217081624543.jpg (GRAPHIC) — 3KB
- 0001193125-24-281283.txt ( ) — 232KB
- dbvt-20241216.xsd (EX-101.SCH) — 3KB
- dbvt-20241216_def.xml (EX-101.DEF) — 14KB
- dbvt-20241216_lab.xml (EX-101.LAB) — 22KB
- dbvt-20241216_pre.xml (EX-101.PRE) — 14KB
- d895886d8k_htm.xml (XML) — 6KB
Financial Statements and Exhibits
Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 10.1 Letter Agreement, dated as of December 16, 2024, amending the Employment Agreement dated July 19, 2019, by and between DBV Technologies, Inc. and Pharis Mohideen. 10.2 English Summary Translation of Letter Agreement, dated as of December 16, 2024, amending the Employment Agreement dated November 6, 2023, by and between DBV Technologies, Inc. and Virginie Boucinha. 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 18, 2024 DBV TECHNOLOGIES S.A. By: /s/ Virginie Boucinha Name: Virginie Boucinha Title: Chief Financial Officer